Skip to main content
. 2017 Jun 27;8(38):63084–63095. doi: 10.18632/oncotarget.18647

Figure 5. MTA3 was obviously decreased in ccRCC patients.

Figure 5

Western blot was performed to show that protein level of MTA3 was dominantly decreased in ccRCC patients.